Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
06/2011
06/23/2011US20110152562 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING a-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
06/23/2011US20110152536 Process for Production of Alpha-Trifluoromethyl-Beta-Substituted-Beta-Amino Acid
06/23/2011US20110152532 Process For The Preparation Of 1-Alkyl And 1-Aryl-5-pyrazolecarboxylic Acid Derivatives
06/23/2011US20110152466 Amide-extended crosslinking compounds and methods for use thereof
06/23/2011US20110152271 Compositions and methods for ophthalmic delivery of nasal decongestants
06/23/2011US20110152220 Methods of diagnosing, preventing and treating bone mass diseases
06/23/2011US20110152210 Polyphenol compounds for inhibiting proteasome and uses thereof
06/23/2011US20110151089 Composition containing magnesium glutamate which can enhance the saltiness of foods and drinks
06/23/2011US20110151022 Thiotungstate analogues and uses thereof
06/23/2011US20110150764 Stroke-tageting peptide and use thereof
06/23/2011CA2784544A1 Process for the preparation of thyroid hormones and salts thereof
06/23/2011CA2784526A1 Process for the preparation of chelated compounds
06/22/2011EP2336114A1 Process for the synthesis of L-3,4 dihydroxy-6-[18F]fluoro-phenylalanine and 2-[18F]Fluor-L-tyrosine and their alpha-methylated derivatives starting from a precursor
06/22/2011EP2334620A2 Process for enantioseparation of chiral systems with compound formation using two subsequent crystallization steps
06/22/2011EP2102147B1 Chiral cyclic beta-amino acids and their derivates, pharmaceutical compositions containing them and the use of such compounds
06/22/2011CN102102114A Preparation of pregabalin and related compounds
06/21/2011US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth
06/21/2011CA2446429C Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
06/21/2011CA2370143C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
06/16/2011WO2011071520A1 Processes for the preparation of (s)-3-(aminomethyl)-5-methylhexanoic acid
06/16/2011WO2011070459A1 Process for enantiomerically pure 8-aryloctanoic acids as aliskiren
06/16/2011WO2011070028A1 Kinetic resolution
06/16/2011WO2011069915A1 Composition for external use and method for producing the same
06/16/2011WO2010149308A3 Substituted benzoxa (thia) zoles
06/16/2011US20110144483 Imaging agents
06/16/2011US20110144376 Dermatological agent
06/16/2011US20110144369 Amino acid group-modified organopolysiloxane and silane, amino acid group-containing compound, and production method thereof
06/16/2011US20110144207 Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
06/16/2011US20110144170 Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS
06/16/2011US20110144037 Substrates and Inhibitors of Antiplasmin Cleaving Enzyme and Fibroblast Activation Protein and Methods of Use
06/16/2011US20110143951 Mass markers and methods
06/16/2011US20110142765 Novel phloroglucinol derivatives having selectin ligand activity
06/16/2011US20110140041 Polymerizable liquid crystal compounds, polymerizable liquid crystal compositions, liquid crystalline polymers and optically anisotropic materials
06/16/2011US20110138683 Gemini surfactants, process of manufacture and use as multifunctional corrosion inhibitors
06/15/2011EP2331492A1 Method for preparing the ethyl ester of 4-[trans-4-[(phenylmethyl)­amino]cyclohexyl]benzoic acid and the hemifumarate salt thereof
06/15/2011CN102099482A Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester
06/15/2011CN102098930A Complex product with advanced assimilation efficacy for humans and its utilization
06/15/2011CN102093239A Alkoxyalkyl Spirocyclic Tetramic Acids and Tetronic Acids
06/15/2011CN102093238A Novel method for crystallizing L-phenylalanine
06/15/2011CN102093237A Synthesis method of gabapentin hydrochloride
06/15/2011CN102093236A Ornithine aspartate compound and new preparation method thereof
06/15/2011CN102093235A Novel method for extracting glutamic acid
06/15/2011CN102093234A Tromethamine salt compound of dibasic ester acid, preparation method and medicinal application thereof
06/15/2011CN102093149A Method for preparing carboxylic acid compound by promoting rapid hydrolysis of cyan
06/15/2011CN101323581B Synthetic method of beet alkali and beet alkali hydrochlorate
06/15/2011CN101289409B Process for preparing 11-aminoundecanoic acid by ammoniation catalysis method
06/15/2011CN101104598B Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives
06/14/2011US7960588 Benzyl cycloalkyl sphingosine 1-phosphate receptor modulators
06/14/2011US7960583 Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
06/14/2011US7960578 Method for the synthesis of peptides without solvent
06/14/2011CA2616910C Non-steroidal androgen receptor modulators, preparation process, pharmaceutical composition and use thereof
06/14/2011CA2433667C Prodrugs of excitatory amino acids
06/14/2011CA2369591C Disodium salts, monohydrate, and ethanol solvates
06/09/2011WO2011067266A1 Carboxylic acid analogs as glycogen synthase activators
06/09/2011WO2011046597A8 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using nmr
06/09/2011US20110137079 Metal oxide-chelating ligands
06/09/2011US20110137068 Method for producing amide derivative
06/09/2011US20110137025 Chemical framework compositions and methods of use
06/09/2011US20110137000 Method for preparing polymer materials doped with metal elements and resulting materials
06/09/2011US20110136911 Treatment of sepsis and inhibition of mif by d-t4
06/09/2011US20110136877 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders
06/09/2011US20110136726 Novel antimicrobial agents
06/09/2011US20110132439 Fullerene compounds for solar cells and photodetectors
06/08/2011CN102089273A Novel process
06/08/2011CN102089272A Method for synthesising 9-aminononanoic acid or the esters thereof from natural unsaturated fatty acids
06/08/2011CN102089271A Method for synthesising omega-amino-alkanoic acids or the esters thereof from natural fatty acids
06/08/2011CN102086159A Glutamic acid extraction method
06/08/2011CN102086158A Method for synthesizing 3-(N,N-2-substituted amino)-2-substituted acrylic esters
06/08/2011CN102086157A Crystal transition tank for producing glutamic acid
06/08/2011CN101234993B Method for preparing 5-aminoisophthalic acid from 5-nitroisophthalic acid
06/08/2011CN101171226B Method for producing methylglycine-N,N-diethanoic acid-trialkali metal salts with a low by-product content
06/07/2011US7956218 Organic salts of β-alanine
06/07/2011US7956217 Hydrolyzed nitrilotriacetonitrile compositions, nitrilotriacetonitrile hydrolysis formulations and methods for making and using same
06/07/2011US7956216 Alpha-helical mimetics
06/07/2011US7956212 Levodopa prodrugs, and compositions and uses thereof
06/07/2011US7956195 reacting arylboronic acids with a cycloalkanone, in the presence of a rhodium catalyst or BINAP, to form a substituted arylcycloalkanone, then formin of a hydantoin, alkylation of the hydantoin, resolution, hydrolysis of the hydantoin to the amino acids and esterification of acids; chemical intermediates
06/07/2011US7956093 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins
06/07/2011US7954643 Use of a derivative of aspartic acid as a collector in froth flotation processes
06/07/2011CA2613155C Substituted cyclobutane,its preparation process and its medical use
06/02/2011US20110131029 Crystal structure of the influenza virus polymerase pac-pb1n complex and uses thereof
06/02/2011US20110130509 (meth)acrylate monomer, polymer and coating agent
06/02/2011US20110130456 Hair Growth Regulating Agent
06/02/2011US20110130448 Functionalized phenolic esters and amides and polymers therefrom
06/02/2011US20110130438 Aniline analogs as glycogen synthase activators
06/02/2011US20110130327 Multi-Arm Amines and Uses Thereof
06/02/2011US20110129762 Method of increasing hydrophilic property of crystalline carbon using surface modifier and method of preparing platinum catalyst using the same
06/02/2011US20110126734 Functionalized zirconia nanoparticles and high index films made therefrom
06/01/2011EP2327685A1 Process for production of -trifluoromethyl- -substituted- -amino acid
06/01/2011EP2327395A1 Process for the preparation of gadobenate dimeglumine complex in a solid form
06/01/2011EP2121960B1 Process for the preparation of beta-lactam compounds
06/01/2011CN102083780A Diglycidic ether derivative therapeutics and methods for their use
06/01/2011CN102083773A {F-19} -labeled L-glutamic acid and L-glutamine derivative (III), use thereof and method for obtaining them
06/01/2011CN102083772A Novel [F-18] -labelled L-glutamic acid- and L-glutamine derivatives (I), use thereof and method for their production
06/01/2011CN102079717A Arginine salt compound of dibasic ester acids and preparation method and medicinal application thereof
06/01/2011CN102079715A Lysine salt compound of binary ester acid, preparation method and medicinal application
06/01/2011CN102079714A Method and equipment for separating alpha-ketoleucine from water by integrating continuous multistage countercurrent liquid-liquid extraction with rectification under reduced pressure
06/01/2011CN102079703A Method for preparing novel nonsteroidal anti-inflammatory drug and anti-inflammatory and analgesic effects thereof
06/01/2011CN101225049B Beta-elemene amino acid derivatives as well as synthetic method and use thereof
05/2011
05/31/2011US7951842 cosmetic; promotes excellent softness and mildness to skin and hair while exhibiting high-foam performance
05/31/2011US7951835 Crystals of non-natural-type stereoisomer salt of monatin and use thereof
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 215